bpc-157 human dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or bpc-157 typical dosage human use
Description
The smaller 10mL multi-use vial format is well suited for laboratory settings requiring precise measurement, reduced material waste, and controlled peptide preparation procedures
Researchers should follow established storage protocols
There is insufficient evidence for the use of B12, beyond correction of deficiency, in cognitive impairment, depression and fatigue
Grabarevic Z, Tisljar M, Artukovic B, et al
